Skip to main content

Table 3 C-reactive protein and nerve-growth-factor levels in urine and serum samples

From: Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders

  CRP urine
ng/ml
CRP/Crea urine CRP serum ng/ml NGF urine NGF/Crea urine NGF serum
pg/ml
Control 1.08
(0–1.76)
0.01
(0–0.02)
946
(0–6820)
76.60
(7.17-250)
0.50
(0.06-3.01)
179
(104–250)
Neurological Disorders 2.21
(0–11.39)
0.04
(0–0.26)
22452
(0–208658)
31.98
(0–150)
0.61
(0–2.41)
164
(40–250)
SC 01.45
(0–14.91)
0.02
(0–0.1721)
14764
(0–92035)
63.24
(0–198)
1.00
(0–3.43)
166
(24.77-250)
SC MD 9.22
(0–131)
0.12
(0–1.1462)
9235
(0–81719)
58.11
(0–250)
0.73
(0–4.40)
167
(46–250)
  1. C-reactive protein (CRP) and nerve-growth-factor (NGF) levels in urine and serum samples (mean, range in brackets), CRP/Creatinine and NGF/Creatinine ratios in the different groups: control group (n = 20), neurological disorders (n = 14), spinal cord disorders without micturition dysfunctions (SC) (n = 15) and spinal cord disorders with micturition dysfunctions (SC MP) (n = 27)